Asunto(s)
Células de la Médula Ósea/patología , Glicoproteínas/análisis , Leucemia Mieloide Aguda/diagnóstico , Lisofosfolipasa/análisis , Necrosis/diagnóstico , Adulto , Células de la Médula Ósea/química , Histocitoquímica , Humanos , Leucemia Mieloide Aguda/metabolismo , Leucemia Mieloide Aguda/patología , Masculino , Necrosis/metabolismo , Necrosis/patologíaAsunto(s)
Grosor Intima-Media Carotídeo , Enfermedad de la Arteria Coronaria/fisiopatología , Enfermedades de von Willebrand/complicaciones , Adulto , Arterias Carótidas/diagnóstico por imagen , Estudios de Casos y Controles , Enfermedad de la Arteria Coronaria/complicaciones , Femenino , Humanos , Masculino , Persona de Mediana Edad , Factores de RiesgoRESUMEN
BACKGROUND/OBJECTIVES: The traditional view that patients with hemophilia are protected against cardiovascular disease is under debate. The aim of the present study was to evaluate the presence and extent of atherosclerosis by coronary artery calcification score (CACS) and carotid intima media thickness (IMT) in patients with hemophilia, and to evaluate their cardiovascular risk profile. METHODS: Sixty-nine patients (51 with hemophilia A; 18 with hemophilia B) were studied [median age: 52 years (interquartile range [IQR] 4364)]. Cardiovascular risk factors and prior major adverse cardiovascular events (MACEs) were recorded. CACS was derived from electron-beam or dual-source computed tomography, and carotid IMT was assessed by ultrasound measurements and compared with age-specific reference values. RESULTS: The median CACS in all patients was 35 (IQR 0110) and the geometric mean IMT was 0.80 mm (95% confidence interval [CI] 0.760.84); neither was different from the reference values. Patients with a previous MACE (n = 9) had significantly higher CACS and IMT than patients without a previous MACE:CACS median 1013 (IQR 5301306) vs. 0 (IQR 067), and IMT geometric mean 1.09 mm (95% CI 0.951.26) vs. 0.76 mm (95% CI 0.730.79), both P < 0.001. A higher calculated 10-year cardiovascular risk was related to higher IMT and CACS. CONCLUSION: Patients with hemophilia are not protected against the development of atherosclerosis as measured by CACS and IMT. The extent of atherosclerosis is related to the traditional cardiovascular risk factors. This suggests that traditional cardiovascular risk factors should be monitored and treated in patients with hemophilia.
Asunto(s)
Aterosclerosis/etiología , Enfermedad de la Arteria Coronaria/diagnóstico , Enfermedad de la Arteria Coronaria/etiología , Hemofilia A/complicaciones , Calcinosis , Grosor Intima-Media Carotídeo , Humanos , Persona de Mediana Edad , Riesgo , Tomografía Computarizada por Rayos XAsunto(s)
Citomegalovirus , Enfermedad Injerto contra Huésped/virología , Trasplante de Células Madre Hematopoyéticas/efectos adversos , Infecciones por Herpesviridae/fisiopatología , Herpesvirus Humano 6 , Activación de Linfocitos/inmunología , Linfocitos/patología , Linfocitos/virología , Activación Viral , Femenino , Humanos , MasculinoAsunto(s)
Factor VIII/antagonistas & inhibidores , Deficiencia del Factor XIII/inducido químicamente , Fluvoxamina/efectos adversos , Inhibidores Selectivos de la Recaptación de Serotonina/efectos adversos , Anciano , Deficiencia del Factor XIII/diagnóstico , Femenino , Humanos , Tiempo de Tromboplastina Parcial , Tiempo de ProtrombinaRESUMEN
Neurofibromatosis type I patients usually present themselves with multiple neurofibromas and cafe-au-lait spots. We report a case with an intracerebral haemorrhage as an uncommon feature of the disease. The clinical, radiological, neurosurgical and histological features of this case are discussed and a review of the literature on the broad spectrum of neurofibromatosis is presented. The etiological factors and clinical consequences of this and other cerebrovascular features are briefly discussed.